About
Technology
Issues
FAQ
Links
Official Page
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.